Comparison between Injecto Polymers IPO and KRM Ayurveda IPO.
Injecto Polymers IPO is a SME Bookbuilding IPO proposed to list at BSE SME while KRM Ayurveda IPO is a SME Bookbuilding proposed to list at NSE SME.
| Injecto Polymers IPO | KRM Ayurveda IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Indcap Advisors Pvt.Ltd. | NEXGEN Financial Solutions Pvt. Ltd. |
| Registrar | Integrated Registry Management Services Pvt.Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | Mansi Share & Stock Broking Pvt.Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Injecto Polymers IPO is up to ₹0.00 Cr whereas the issue size of the KRM Ayurveda IPO is up to ₹69.74 Cr. The final issue price of Injecto Polymers IPO is and of KRM Ayurveda IPO is ₹135.00 per share.
| Injecto Polymers IPO | KRM Ayurveda IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹128.00 per share | |
| Issue Price (Upper) | ₹135.00 per share | |
| Issue Price (Final) | ₹135.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1000 shares | |
| Fresh Issue Size | 56,13,500 shares | 51,66,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹69.74 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 56,13,500 shares | 51,66,000 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹69.74 Cr |
Injecto Polymers IPO opens on , while KRM Ayurveda IPO opens on Jan 21, 2026. The closing date of Injecto Polymers IPO and KRM Ayurveda IPO is , and Jan 23, 2026, respectively.
| Injecto Polymers IPO | KRM Ayurveda IPO | |
|---|---|---|
| Anchor Bid Date | Jan 20, 2026 | |
| Issue Open | Jan 21, 2026 | |
| Issue Close | Jan 23, 2026 | |
| Basis Of Allotment (Tentative) | Jan 27, 2026 | |
| Initiation of Refunds (Tentative) | Jan 28, 2026 | |
| Credit of Share (Tentative) | Jan 28, 2026 | |
| Listing date (Tentative) | Jan 29, 2026 | |
| Anchor Lockin End date 1 | Feb 21, 2026 | |
| Anchor Lockin End date 2 | Apr 22, 2026 |
Injecto Polymers IPO P/E ratio is , as compared to KRM Ayurveda IPO P/E ratio of 17.32.
| Injecto Polymers IPO | KRM Ayurveda IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Injecto Polymers Ltd.'s revenue increased by 138% and profit after tax (PAT) rose by 82% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 88.14 | 92.16 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 67.28 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 17.32 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹287.02 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 23.66 | 67.86 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 13.91 | 43.33 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.14 | 1.31 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹7.79 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 17.13 | 67.86 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Injecto Polymers IPO Retail Individual Investors (RII) are offered 0 shares while in KRM Ayurveda IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Injecto Polymers IPO and 10,32,000 shares in KRM Ayurveda IPO.
| Injecto Polymers IPO | KRM Ayurveda IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 15,42,000 shares |
| Market Maker Reservation | 0 shares | 5,74,000 shares |
| QIB | 0 shares | 10,32,000 shares |
| NII | 0 shares | 7,80,000 shares |
| RII | 0 shares | 18,12,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 51,66,000 shares |
Injecto Polymers IPO subscribed in total, whereas KRM Ayurveda IPO subscribed 74.27x.
| Injecto Polymers IPO | KRM Ayurveda IPO | |
|---|---|---|
| QIB (times) | 63.31x | |
| NII (times) | 135.37x | |
| Big NII (times) | 166.53x | |
| Small NII (times) | 73.04x | |
| RII (times) | 54.21x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 74.27x |
